
Jake Minh Vu
Examiner (ID: 14384, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1094 |
| Issued Applications | 353 |
| Pending Applications | 146 |
| Abandoned Applications | 625 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18673168
[patent_doc_number] => 20230310661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => OPHTHALMIC DYE
[patent_app_type] => utility
[patent_app_number] => 18/042779
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042779
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042779 | OPHTHALMIC DYE | Aug 25, 2021 | Pending |
Array
(
[id] => 17441669
[patent_doc_number] => 20220062174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Therapeutic Medical Device and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 17/412231
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412231 | Therapeutic Medical Device and Methods of Use | Aug 24, 2021 | Pending |
Array
(
[id] => 19550173
[patent_doc_number] => 12133865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Compositions and therapies using nanodiamonds suspended in a carrier
[patent_app_type] => utility
[patent_app_number] => 17/401589
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 11931
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401589 | Compositions and therapies using nanodiamonds suspended in a carrier | Aug 12, 2021 | Issued |
Array
(
[id] => 18595317
[patent_doc_number] => 20230270105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => BACTROCERA OLEAE ATTRACTANT COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/040585
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040585
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040585 | None | Aug 9, 2021 | Issued |
Array
(
[id] => 17426959
[patent_doc_number] => 20220054667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => INVISIBLE SINGLET FILM
[patent_app_type] => utility
[patent_app_number] => 17/389936
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389936 | INVISIBLE SINGLET FILM | Jul 29, 2021 | Abandoned |
Array
(
[id] => 17198522
[patent_doc_number] => 20210338616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => LIQUID DOSAGE FORMS OF SODIUM NAPROXEN
[patent_app_type] => utility
[patent_app_number] => 17/374564
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374564 | LIQUID DOSAGE FORMS OF SODIUM NAPROXEN | Jul 12, 2021 | Abandoned |
Array
(
[id] => 18610966
[patent_doc_number] => 20230277696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ULTRASOUND-SENSITIVE BIODEGRADEABLE MULTI-CAVITY MICRO-PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/010216
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010216 | ULTRASOUND-SENSITIVE BIODEGRADEABLE MULTI-CAVITY MICRO-PARTICLES | Jun 15, 2021 | Pending |
Array
(
[id] => 18610966
[patent_doc_number] => 20230277696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ULTRASOUND-SENSITIVE BIODEGRADEABLE MULTI-CAVITY MICRO-PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/010216
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010216 | ULTRASOUND-SENSITIVE BIODEGRADEABLE MULTI-CAVITY MICRO-PARTICLES | Jun 15, 2021 | Pending |
Array
(
[id] => 18511671
[patent_doc_number] => 20230227852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/009290
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009290
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009290 | ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS SYSTEM | Jun 10, 2021 | Pending |
Array
(
[id] => 17273009
[patent_doc_number] => 20210379207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => EMBOLIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/342945
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342945
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342945 | Embolic compositions and methods | Jun 8, 2021 | Issued |
Array
(
[id] => 17110192
[patent_doc_number] => 20210290789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/337357
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337357 | RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY | Jun 1, 2021 | Pending |
Array
(
[id] => 18433454
[patent_doc_number] => 20230180748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => BIOACTIVE COMPOSITION FOR KILLING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/926583
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926583 | BIOACTIVE COMPOSITION FOR KILLING CELLS | May 25, 2021 | Pending |
Array
(
[id] => 19058992
[patent_doc_number] => 11938186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Thermosensitive hydrogel for cancer therapeutics and methods of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/325290
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7209
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325290 | Thermosensitive hydrogel for cancer therapeutics and methods of preparation thereof | May 19, 2021 | Issued |
Array
(
[id] => 17124488
[patent_doc_number] => 20210299256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => ULTRASOUND MEDIATED DELIVERY OF DRUGS
[patent_app_type] => utility
[patent_app_number] => 17/302917
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302917 | Ultrasound mediated delivery of drugs | May 13, 2021 | Issued |
Array
(
[id] => 17124488
[patent_doc_number] => 20210299256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => ULTRASOUND MEDIATED DELIVERY OF DRUGS
[patent_app_type] => utility
[patent_app_number] => 17/302917
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302917 | Ultrasound mediated delivery of drugs | May 13, 2021 | Issued |
Array
(
[id] => 17212943
[patent_doc_number] => 20210346279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMPOSITIONS COMPRISING TAPINAROF FOR THE TREATMENT OF PRURITIS
[patent_app_type] => utility
[patent_app_number] => 17/313136
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313136 | COMPOSITIONS COMPRISING TAPINAROF FOR THE TREATMENT OF PRURITIS | May 5, 2021 | Abandoned |
Array
(
[id] => 17298010
[patent_doc_number] => 20210393849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Implantable Embolic Scaffolds That Promote Healing
[patent_app_type] => utility
[patent_app_number] => 17/306482
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306482 | Implantable Embolic Scaffolds That Promote Healing | May 2, 2021 | Abandoned |
Array
(
[id] => 17035019
[patent_doc_number] => 20210251977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => TRANSMUCOSAL DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/246852
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246852 | TRANSMUCOSAL DRUG DELIVERY SYSTEM | May 2, 2021 | Abandoned |
Array
(
[id] => 17183759
[patent_doc_number] => 20210330644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMBINATION THERAPY FOR TREATING METASTATIC PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/227024
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227024
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227024 | COMBINATION THERAPY FOR TREATING METASTATIC PROSTATE CANCER | Apr 8, 2021 | Abandoned |
Array
(
[id] => 17154987
[patent_doc_number] => 20210316038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => ANTIBIOTIC ELUTING POLY(ESTER UREA) FILMS, MESHES AND POUCHES FOR INFECTION CONTROL OF IMPLANTABLE MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/209921
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209921 | ANTIBIOTIC ELUTING POLY(ESTER UREA) FILMS, MESHES AND POUCHES FOR INFECTION CONTROL OF IMPLANTABLE MEDICAL DEVICES | Mar 22, 2021 | Pending |